Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 2 | U8375AA | IM / RA |
After administration of the TB test and MenQuadfi (MCV4) vaccine, the patient reported feeling dizzy, appeared pale, and experienced a brief syncopal episode lasting approximately 30 seconds while seated in a chair with armrests down. The nurse immediately called for assistance and initiated assessment and supportive care. The patient was provided with juice, which she tolerated well. She reported feeling slightly better. Shortly afterward, the patient experienced nausea and was provided with an emesis bag. One episode of emesis occurred, estimated at approximately 100 mL of fluid. Initial vital signs were as follows: Blood Pressure: 89/50 mmHg Pulse: 68 bpm The patient reported feeling improved. A second set of vital signs was taken: Blood Pressure: 90/57 mmHg Pulse: 70 bpm A snack was offered twice but declined; the patient accepted a bottle of water and continued to drink both juice and water. She reported feeling significantly better. Final set of vital signs prior to discharge: Blood Pressure: 95/60 mmHg Pulse: 71 bpm The nurse accompanied the patient and her partner to their vehicle. A steady gait was observed with no signs of instability upon standing or walking. The patient s partner confirmed he would be driving the patient home. Discharge instructions were provided, including advice to eat a meal as soon as possible and to seek immediate medical attention at the nearest emergency clinic if any further symptoms arise. The patient verbalized understanding.
none
none
TUBERSOL
none
NA
at approximately age 15 with unknown vaccine. As per patient she had a fainting episode after receiving vaccine and recovered r